Atara Biotherapeutics, Inc. (LON:0HIY)
London · Delayed Price · Currency is GBP · Price in USD 17.81
+2.80 (18.69%)
Jan 9, 2026, 6:00 AM GMT
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of 93.62 million as of January 8, 2026. Its market cap has increased by 105.59% in one year.
Market Cap
93.62M
Enterprise Value
96.03M
Revenue
113.03M
Ranking
n/a
PE Ratio
5.38
Stock Price
17.81
Market Cap Chart
Since October 17, 2014, Atara Biotherapeutics's market cap has decreased from 144.86M to 93.62M, a decrease of -35.37%. That is a compound annual growth rate of -3.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 79.95M | -17.50% |
| Dec 31, 2025 | 96.91M | 58.26% |
| Dec 31, 2024 | 61.24M | 49.24% |
| Dec 29, 2023 | 41.03M | -84.11% |
| Dec 30, 2022 | 258.28M | -74.90% |
| Dec 31, 2021 | 1.03B | -13.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.72B |
| GSK plc | 76.21B |
| Haleon | 33.53B |
| Smith & Nephew | 10.67B |
| Convatec Group | 4.76B |
| Hikma Pharmaceuticals | 3.51B |
| HUTCHMED (China) | 1.81B |
| Genus | 1.72B |